BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28885737)

  • 1. Vascular Pattern Analysis on Microvascular Sonography for Differentiation of Pleomorphic Adenomas and Warthin Tumors of Salivary Glands.
    Ryoo I; Suh S; Lee YH; Seo HS; Seol HY; Woo JS; Kim SC
    J Ultrasound Med; 2018 Mar; 37(3):613-620. PubMed ID: 28885737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sonoelastography, B-mode sonography, and color Doppler sonography findings of pleomorphic adenomas and Warthin tumors of parotid gland].
    Yerli H; Eşki E
    Kulak Burun Bogaz Ihtis Derg; 2015; 25(6):329-36. PubMed ID: 26572176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonographic and sonoelastographic features of pleomorphic adenomas of the salivary glands.
    Dumitriu D; Dudea SM; Botar-Jid C; Băciuţ G
    Med Ultrason; 2010 Sep; 12(3):175-83. PubMed ID: 21203593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray-scale and color Doppler ultrasonographic features of pleomorphic adenoma and Warthin's tumor in major salivary glands.
    Yuan WH; Hsu HC; Chou YH; Hsueh HC; Tseng TK; Tiu CM
    Clin Imaging; 2009; 33(5):348-53. PubMed ID: 19712813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of pleomorphic adenoma and Warthin's tumor of the parotid gland: ultrasonographic features.
    Rong X; Zhu Q; Ji H; Li J; Huang H
    Acta Radiol; 2014 Dec; 55(10):1203-9. PubMed ID: 24324278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative diagnosis of salivary gland tumors with contrast-enhanced ultrasound--a preliminary study.
    Gou JM; Chen Q; Zhou Q; Liu YX
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Dec; 116(6):784-90. PubMed ID: 24209995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of pleomorphic adenomas, adenolymphomas, and malignant tumors of the salivary glands on color doppler ultrasonography and contrast enhanced ultrasonography.
    Jiang LP
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11509-11517. PubMed ID: 33275217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of Superb Microvascular Imaging in identifying benign tumors of parotid gland.
    Zhao L; Mao Y; Mu J; Zhao J; Li F; Zhang S; Xin X
    BMC Med Imaging; 2020 Sep; 20(1):107. PubMed ID: 32938423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color Doppler sonography of salivary glands.
    Martinoli C; Derchi LE; Solbiati L; Rizzatto G; Silvestri E; Giannoni M
    AJR Am J Roentgenol; 1994 Oct; 163(4):933-41. PubMed ID: 8092039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of salivary gland tumors through tumor heterogeneity: a comparison between pleomorphic adenoma and Warthin tumor using CT texture analysis.
    Jung YJ; Han M; Ha EJ; Choi JW
    Neuroradiology; 2020 Nov; 62(11):1451-1458. PubMed ID: 32621023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Color Doppler ultrasound studies of parotid tumors].
    Benzel W; Zenk J; Iro H
    HNO; 1995 Jan; 43(1):25-30. PubMed ID: 7890547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland tumours: is colour Doppler imaging of added value in their preoperative assessment?
    Ajayi BA; Pugh ND; Carolan G; Woodcock JP
    Eur J Surg Oncol; 1992 Oct; 18(5):463-8. PubMed ID: 1330705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic texture characterization of salivary gland tumors by fractal analyses.
    Chikui T; Tokumori K; Yoshiura K; Oobu K; Nakamura S; Nakamura K
    Ultrasound Med Biol; 2005 Oct; 31(10):1297-304. PubMed ID: 16223632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of Qualitative Elastography Using Acoustic Radiation Force Impulse for Differentiating Benign from Malignant Salivary Gland Tumors.
    Matsuda E; Fukuhara T; Donishi R; Taira K; Koyama S; Morisaki T; Fujiwara K; Takeuchi H
    Ultrasound Med Biol; 2021 Feb; 47(2):279-287. PubMed ID: 33189412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
    Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
    NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Experience With Ultrasound Elastography for Diagnosis of Major Salivary Gland Lesions.
    Zhou H; Zhou XL; Xu HX; He YP; Bo XW; Li XL; Liu BJ; Li DD; Wang D
    J Ultrasound Med; 2016 Dec; 35(12):2597-2606. PubMed ID: 27872416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of a Novel Ultrasonographic Classification Based on Anechoic Area Patterns for Differentiating Warthin Tumors from Pleomorphic Adenomas of the Parotid Gland.
    Matsuda E; Fukuhara T; Donishi R; Kawamoto K; Hirooka Y; Takeuchi H
    Yonago Acta Med; 2017 Dec; 60(4):220-226. PubMed ID: 29434491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced ultrasonography for the differential diagnosis of pleomorphic adenomas and Warthin tumors in salivary glands.
    Saito D; Shiga K; Katagiri K; Oikawa SI; Ikeda A; Tsuchida K; Miyaguchi J; Kusaka T; Kuroda H; Takahashi F
    Laryngoscope Investig Otolaryngol; 2021 Jun; 6(3):425-431. PubMed ID: 34195363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors.
    Hisatomi M; Asaumi J; Yanagi Y; Unetsubo T; Maki Y; Murakami J; Matsuzaki H; Honda Y; Konouchi H
    Oral Oncol; 2007 Oct; 43(9):940-7. PubMed ID: 17257881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging.
    Shao S; Zheng N; Mao N; Xue X; Cui J; Gao P; Wang B
    Clin Radiol; 2021 Jun; 76(6):472.e11-472.e18. PubMed ID: 33752882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.